Reaction

Multifocal Micronodular Pneumocyte Hyperplasia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 34 reports · 2 co-occurring drugs

As of the last recalculation, Multifocal Micronodular Pneumocyte Hyperplasia appears in 34 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is DOCETAXEL ANHYDROUS (PRR 738.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Docetaxel Anhydrous24738.8739.1
Docetaxel24738.8739.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.